Mark Stenhouse's Net Worth
$3.5 Million
Who is Mark Stenhouse?
Mark Stenhouse has an estimated net worth of $3.5 Million. This is based on reported shares across multiple companies, which include Prometheus Biosciences, Inc., EXACT SCIENCES CORP, and Phathom Pharmaceuticals, Inc..
SEC CIK
Mark Stenhouse's CIK is 0001734751
Past Insider Trading and Trends
2020 was Mark Stenhouse's most active year for acquiring shares with 5 total transactions. Mark Stenhouse's most active month to acquire stocks was the month of January. 2023 was Mark Stenhouse's most active year for disposing of shares, totalling 8 transactions. Mark Stenhouse's most active month to dispose stocks was the month of May. 2021 saw Mark Stenhouse paying a total of $266,000.00 for 96,871 shares, this is the most they've acquired in one year. In 2019 Mark Stenhouse cashed out on 36,192 shares for a total of $1,035,696.49, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Prometheus Biosciences, Inc. No price found
Chief Operating Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -26.75K |
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
| 26.71K |
Jun 1
| |||
Form 4
| +58.99% | 9.81K |
—
|
—
| 26.44K |
Dec 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 14
| |||
Form 4
|
∞
| 14K |
$19.00 | $266,000.00 | 14K |
Mar 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
EXACT SCIENCES CORP (EXAS) Snapshot price: $64.57
President, Cologuard
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +79.01% | 13.05K |
$56.69 | -$677,332.12 | 29.57K |
Scheduled
|
Apr 2 - Apr 3
| ||
Form 4
| +15.45% | 2.21K |
$80.27 | -$84,363.77 | 16.52K |
Scheduled
|
Feb 26 - Feb 27
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 14
| |||
Form 4
| +2,761.60% | 13.81K |
$92.54 | -$1,035,696.49 | 14.31K |
Scheduled
|
Apr 2 - Apr 3
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Phathom Pharmaceuticals, Inc. (PHAT) Snapshot price: $7.025
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 9K |
—
|
—
| 9K |
May 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||